Roanoke Asset Management’s DexCom DXCM Stock Holding History

Roanoke Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,060	Closed	-$393K	–	98
2023 Q2	$393K	Hold	3,060	–	–	0.16%	80
2023 Q1	$356K	Hold	3,060	–	–	0.15%	82
2022 Q4	$347K	Hold	3,060	–	–	0.16%	86
2022 Q3	$246K	Hold	3,060	–	–	0.12%	96
2022 Q2	$228K	Hold	3,060	–	–	0.1%	98
2022 Q1	$391K	Hold	3,060	–	–	0.15%	90
2021 Q4	$411K	Sell	3,060 -60	-2%	-$8.62K	0.14%	85
2021 Q3	$427K	Hold	3,120	–	–	0.15%	80
2021 Q2	$333K	Hold	3,120	–	–	0.12%	88
2021 Q1	$280K	Hold	3,120	–	–	0.12%	88
2020 Q4	$288K	Hold	3,120	–	–	0.14%	84
2020 Q3	$322K	Sell	3,120 -880	-22%	-$91.9K	0.18%	78
2020 Q2	$405K	Sell	4,000 -80	-2%	-$7.16K	0.23%	69
2020 Q1	$275K	Hold	4,080	–	–	0.19%	78
2019 Q4	$223K	Buy	+4,080	New	+$194K	0.11%	92
2019 Q1	–	Sell	-6,960	Closed	-$208K	–	102
2018 Q4	$208K	Sell	6,960 -240	-3%	-$7.61K	0.11%	96
2018 Q3	$257K	Buy	+7,200	New	+$223K	0.12%	93

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Roanoke Asset Management's DXCM Position: Q3 2023 in Review

Roanoke Asset Management sold out of DexCom (DXCM) in Q3 2023, closing a stake of 3,060 shares — an estimated $393K sold.

Roanoke Asset Management first reported a position in DXCM in Q3 2018 and held it in 17 quarters. The position peaked at $427K in Q3 2021. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

Roanoke Asset Management reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
Roanoke Asset Management sold 3,060 DexCom shares in Q3 2023, an estimated $393K.
Roanoke Asset Management first reported a position in DexCom in Q3 2018 and held it in 17 quarters.
Roanoke Asset Management's DexCom position peaked at $427K in Q3 2021.
903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Roanoke Asset Management's 13F filing for Q3 2023, filed 15 Nov 2023.